Brief: Abvc Biopharma Inc Entered Into A Multi-Year, Global Licensing Agreement With Aibtl Biopharma

ABVC Biopharma

16/11/2023 14:32

Nov 16 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA INC: IN NOV 12, CO AND UNIT EACH ENTERED
INTO A
MULTI-YEAR, GLOBAL LICENSING AGREEMENT WITH AIBTL BIOPHARMA INC
    * ABVC BIOPHARMA INC- AS PER EACH OF THE RESPECTIVE
AGREEMENTS,
EACH OF ABVC AND BIOLITE SHALL RECEIVE 23 MILLION SHARES OF AIBL
STOCK
    * ABVC BIOPHARMA INC: AGREEMENT FOR CO & BIOLITE'S CNS DRUGS
WITH
INDICATIONS OF MAJOR DEPRESSIVE DISORDER & ATTENTION DEFICIT
HYPERACTIVITY DISORDER
    * ABVC BIOPHARMA- IF CERTAIN MILESTONES MET UNDER DEAL, CO &
UNIT
TO GET $3.5 MILLION AND ROYALTIES EQUALING 5% OF NET SALES, UP
TO $100 MILLION FROM AIBL
    * ABVC BIOPHARMA INC: AS PER EACH OF RESPECTIVE AGREEMENTS,
AS A
RESULT OF SHARE ISSUANCE TO COMPANY, IT WILL HAVE A CONTROLLING
INTEREST OVER AIBL

Source text for Eikon:  ID: 
Further company coverage:  ABVC.O 

 ((Reuters.Briefs@thomsonreuters.com;))